Robert Jones
Chief Executive Officer presso ACURA PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/12/2023
Profilo
Robert B.
Jones is currently the President, Chief Executive Officer & Director at Acura Pharmaceuticals, Inc. He previously worked as the VP-Finance, Strategy & Business Analysis at Adolor Corp.
from 2003 to 2008.
He also held the position of Vice President-Marketing & Business Development at Endeavor Pharmaceuticals, Inc. and Vice President-Sales & Marketing at Purepac Pharmaceutical Co. Additionally, he served as the Chief Operating Officer & Vice President-Finance at Opt-e-scrip, Inc. from 2000 to 2003.
Mr. Jones completed his undergraduate degree at Cornell University and holds an MBA from The University of North Carolina at Charlotte.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 20/11/2023 | 643 555 ( 0.98% ) | - $ | 31/12/2023 |
Posizioni attive di Robert Jones
| Società | Posizione | Inizio |
|---|---|---|
| ACURA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/04/2011 |
Precedenti posizioni note di Robert Jones
| Società | Posizione | Fine |
|---|---|---|
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01/03/2008 |
| Opt-e-scrip, Inc. | Director of Finance/CFO | 01/05/2003 |
Endeavor Pharmaceuticals, Inc.
 Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Sales & Marketing | - |
Purepac Pharmaceutical Co.
 Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Sales & Marketing | - |
Formazione di Robert Jones
| Cornell University | Undergraduate Degree |
| The University of North Carolina at Charlotte | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ACURA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endeavor Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on women's health by developing and marketing advanced hormone therapies. The company is headquartered in Wilmington, NC. | Health Technology |
Purepac Pharmaceutical Co.
Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Health Technology |
| Opt-e-scrip, Inc. |
- Borsa valori
- Insiders
- Robert Jones
